CMTR2
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2
Also known as: AFT, CMTR2_HUMAN, FLJ11171, FTSJD1, MTr2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYT2
- Gene
- CMTR2
- Ensembl
- ENSG00000180917
- Chromosome
- 16
- Canonical length
- 770 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nuclear speckles,Cell Junctions
OverviewNCBI Gene
Enables mRNA (nucleoside-2'-O-)-methyltransferase activity. Involved in 7-methylguanosine mRNA capping. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
770 residues, UniProt reviewed canonical sequence.
>Q8IYT2|CMTR2
1 MSKCRKTPVQ QLASPASFSP DILADIFELF AKNFSYGKPL NNEWQLPDPS EIFTCDHTEL
61 NAFLDLKNSL NEVKNLLSDK KLDEWHEHTA FTNKAGKIIS HVRKSVNAEL CTQAWCKFHE
121 ILCSFPLIPQ EAFQNGKLNS LHLCEAPGAF IASLNHYLKS HRFPCHWSWV ANTLNPYHEA
181 NDDLMMIMDD RLIANTLHWW YFGPDNTGDI MTLKFLTGLQ NFISSMATVH LVTADGSFDC
241 QGNPGEQEAL VSSLHYCEVV TALTTLGNGG SFVLKMFTMF EHCSINLMYL LNCCFDQVHV
301 FKPATSKAGN SEVYVVCLHY KGREAIHPLL SKMTLNFGTE MKRKALFPHH VIPDSFLKRH
361 EECCVFFHKY QLETISENIR LFECMGKAEQ EKLNNLRDCA IQYFMQKFQL KHLSRNNWLV
421 KKSSIGCSTN TKWFGQRNKY FKTYNERKML EALSWKDKVA KGYFNSWAEE HGVYHPGQSS
481 ILEGTASNLE CHLWHILEGK KLPKVKCSPF CNGEILKTLN EAIEKSLGGA FNLDSKFRPK
541 QQYSCSCHVF SEELIFSELC SLTECLQDEQ VVVPSNQIKC LLVGFSTLRN IKMHIPLEVR
601 LLESAELTTF SCSLLHDGDP TYQRLFLDCL LHSLRELHTG DVMILPVLSC FTRFMAGLIF
661 VLHSCFRFIT FVCPTSSDPL RTCAVLLCVG YQDLPNPVFR YLQSVNELLS TLLNSDSPQQ
721 VLQFVPMEVL LKGALLDFLW DLNAAIAKRH LHFIIQRERE EIINSLQLQNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CMTR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 17 nTPM
- breast: 15 nTPM
- duodenum: 14 nTPM
- esophagus: 13 nTPM
- lymph node: 13 nTPM
- small intestine: 13 nTPM
Single-cell type
- microglia: 55 nCPM
- distal convoluted tubule cells: 36 nCPM
- choroid plexus epithelial cells: 35 nCPM
- bergmann glia: 26 nCPM
- oligodendrocytes: 25 nCPM
- proximal tubule cells: 25 nCPM
Immune cell
- basophil: 23 nTPM
- NK-cell: 17 nTPM
- myeloid DC: 14 nTPM
- MAIT T-cell: 13 nTPM
- memory B-cell: 13 nTPM
- naive B-cell: 12 nTPM
Brain region
- choroid plexus: 18 nTPM
- white matter: 15 nTPM
- spinal cord: 12 nTPM
- medulla oblongata: 12 nTPM
- hypothalamus: 11 nTPM
- pons: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.13
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- methyltransferase cap1 activity
- methyltransferase cap2 activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ribosomal RNA methyltransferase, FtsJ domain
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- mRNA Cap 2'-O-Ribose Methyltransferase
- FtsJ-like methyltransferase
- Adrift-type ribose 2-O-methyltransferase domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CMTR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CMTR2 as an antibody target. Whether an autoantibody or antibody against CMTR2 could matter depends on whether native CMTR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CMTR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CMTR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...